Form 4: Genelux Corp Director John W. Smither Reports Transaction
SEC Form 4 Filing
Director John W. Smither reports the acquisition and disposal of Genelux Corp common stock and warrants.
Summary
- On May 29, 2024, John W. Smither, a director of Genelux Corp, reported a transaction involving the company's securities.
- The transaction included the acquisition of 6,250 shares of common stock and 6,250 common stock warrants.
- The director also disposed of 13,170 shares of common stock.
- The common stock warrants have an exercise price of $5.25 and expire on May 29, 2029.
- The combined price of each share of common stock offered together with one warrant was $4.00.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing, so the sentiment is neutral.
Industry Context
Form 4 filings are a routine part of regulatory compliance for corporate insiders, providing transparency into their transactions in the company's stock. This filing indicates changes in the director's holdings of Genelux Corp securities.
Stakeholder Impact
- Shareholders may be interested in the trading activity of company insiders as it can provide insights into their perspective on the company's value and prospects.
Key Dates
| Date | Description |
|---|---|
| 05/29/2024 | Date of transaction involving common stock and warrants |
| 05/29/2029 | Expiration date of the common stock warrants |
| 06/07/2024 | Date of signature for the report |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.